Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04088851
NA
"Hepatic Substrate Flux Rates in Type 2 Diabetes"
Sponsor: German Diabetes Center
View on ClinicalTrials.gov
Summary
Investigation of the effects of redox shuttle inhibition by metformin on gluconeogenic flux rates of lactate and glycerol in humans with type 2 diabetes
Official title: "Non-invasive Measurement of Hepatic Substrate Flux Rates in People with Diabetes Mellitus Type 2"
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
23
Start Date
2019-09-11
Completion Date
2025-12-31
Last Updated
2025-01-13
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
On Metformin
Oral intake of Metformin (1 g / day) for 2 weeks
DRUG
Off Metformin
No oral intake of Metformin (1 g / day) for 2 weeks
Locations (1)
German Diabetes Center
Düsseldorf, North Rhine-Westphalia, Germany